NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

RecruitingPhase 3

Sponsor: Oculis

Conditions: Optic Neuritis

Interventions: Privosegtor, Methylprednisolone, Placebo

Countries: United States

The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).

Eligibility overview

Sex: ALL

Age: 18 Years to 50 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Key Inclusion Criteria:

* Adult men and women (aged 18 to 50 years) with the first episode of ON in the study eye, associated with unilateral visual loss.
* Onset of visual loss symptoms in the previous 12 days before first administration of study treatment.

Key Exclusion Criteria:

\- Have a history or presence of any disorder or condition that may, in the opinion of the Investigator, likely interfere with the interpretation of the study results or participant safety

Locations (2)

Livonia, Michigan, United States
Houston, Texas, United States